Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression
Open accessAbstract
SUMMARY While many genetic variants have been associated with risk for human diseases, how these variants affect gene expression in various cell types remains largely unknown. To address this gap, the DICE (Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics) project was established. Considering all human immune cell types and conditions studied, we identified cis-eQTLs for a total of 12,254 unique genes, which represent 61% of all protein-coding genes expressed in these cell types. Strikingly, a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type. We also found that biological sex is associated with major differences in immune cell gene expression in a highly cell-specific manner. These datasets will help reveal the effects of disease risk-associated genetic polymorphisms on specific immune cell types, providing mechanistic insights into how they might influence pathogenesis (http://dice-database.org).
AI snapshot
Written from the paper’s full text.
TL;DR
The DICE project mapped transcriptomes and cis-eQTLs across 13 human immune cell types and activation conditions from 91 healthy subjects, identifying 12,254 eGenes with highly cell-specific genetic effects. It also found extensive sex-biased immune gene expression and linked GWAS disease variants to specific immune cell types.
Key findings
- cis-eQTLs were identified for 12,254 unique genes, representing 61% of expressed protein-coding genes and 49% of lncRNAs; 41% showed a strong cis-association with genotype in only a single cell type. More than 2,000 eGenes were found per common cell type, and CD4+ memory/TREG subsets yielded over 7,800 eGenes, of which >2,500 were unique to those subsets.
- About 19% of eGenes per immune cell type overlapped GWAS SNPs (2,297 unique GWAS eGenes; 599–987 eGenes/cell type), and for about 36% of these eGenes associations were observed in only one or two cell types. Examples included IRAK3 in naïve B cells (rs1732886, adj. P = 6.82 × 10−17) and NAB1 in NK cells (rs13028201, adj. P = 1.41 × 10−14).
- Sex-biased expression was found for 1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs; 93% were autosomal and >72% showed sex-biased expression in only a single immune cell type. FAM13A was female-biased in naïve CD4+ T cells, with homozygous CC versus TT females showing 3.5-fold greater FAM13A transcripts compared to <1.5-fold in males.
- Cell-specific transcriptional signatures included 4,602 highly cell-specific transcripts, and differential expression among CD4+ T cell subsets revealed over 700 genes enriched in one specific subset.
Methods
- The study analyzed 13 immune cell types plus activated naïve CD4+ and CD8+ T cells from 106 leukapheresis samples provided by 91 healthy subjects (54 males, 37 females; median age 27 years, range 18–61).
- RNA-seq was performed on FACS-sorted cells, with genotyping and imputation using the 1,000 Genomes Project phase 3 reference; cis-eQTLs were tested within ±1 Mb of the transcription start site using Matrix eQTL with thresholds FDR < 0.05, raw P < 0.0001, and TPM > 1.0.
- Differential expression used DESeq2; GWAS overlap used PheGenI data with 14,321 lead GWAS SNPs and 846 traits; functional validation used siRNA knockdowns in primary immune cells.
Limitations
- The paper states that next phases of DICE will add additional rare immune cell types and cell-specific epigenomic profiles, and that several lncRNA and disease-gene links require further study and functional confirmation.
- The cohort was limited to 91 healthy volunteers from the San Diego area with a median age of 27 years, so generalizability to older, diseased, or more ancestrally diverse populations is not established by this dataset.
- The eQTL analysis did not cover the pseudoautosomal regions of chr X or chr Y (stated in the paper), and it focused on cis windows of ±1 Mb around the TSS rather than trans effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 4 cited sources checked · 0 supported · 0 flagged
- Findingown data
lncRNAs as a class were expressed at lower levels than protein-coding transcripts.
“which as a class were expressed at lower levels compared to protein-coding transcripts”
Quote in the paperNot a substantial claim - Findingown data
Across all immune cell types and conditions studied, the DICE project identified cis-eQTLs for 12,254 unique genes.
“Considering all human immune cell types and conditions studied, we identified cis-eQTLs for a total of 12,254 unique genes”
Quote in the paperSubstantial claim - Findingown data
RNA-Seq detected similar numbers of transcripts, ranging from 14,500 to 17,000, about 39% of annotated transcripts, across all cell types and activation conditions.
“RNA-Seq analysis showed that similar numbers of transcripts (ranging from 14,500 to 17,000, ~39% of all annotated transcripts) were detected (>1.0 transcripts per million, TPM) across all cell types and activation conditions”
Quote in the paperNot a substantial claim - Findingown data
Biological sex is associated with major differences in immune cell gene expression in a highly cell-specific manner.
“We also found that biological sex is associated with major differences in immune cell gene expression in a highly cell-specific manner.”
Quote in the paperSubstantial claim - Findingown data
The eGenes include 49% of all lncRNAs expressed in the studied immune cell types.
“representing 61% of all expressed protein-coding genes and 49% of all lncRNAs, respectively”
Quote in the paperNot a substantial claim
- Findingown data
A large fraction, 41%, of the eGenes showed a strong cis-association with genotype in only one cell type.
“Strikingly, a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type.”
- Also stated in: § Abstract · plain
“a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
The 12,254 eGenes represent 61% of all protein-coding genes expressed in the studied immune cell types.
“which represent 61% of all protein-coding genes expressed in these cell types”
Quote in the paperSubstantial claim - Findingown data
Several lncRNAs showed high abundance in specific immune cell types.
“Interestingly, several lncRNAs showed high abundance in specific immune cell types.”
Quote in the paperNot a substantial claim - Findingown data
FCRL1 and FCRL2 had strong cis-eQTLs primarily in TREG subsets.
“We also identified 2 genes in the Fc receptor like (FCRL) gene locus that showed strong cis-eQTLs primarily in TREG subsets”
Quote in the paperNot a substantial claim - Findingown data
NCF4 showed prominent cis-QTLs specifically in CD4+ T cell subsets.
“NCF4, which encodes neutrophilic cytosolic factor 4, a component of the NADPH oxidase complex, showed prominent cis-QTLs specifically in CD4+ T subsets”
Quote in the paperNot a substantial claim - Findingown data
The ERAP2 peak eQTL rs2548540 caused genotype-dependent expression differences across all immune cell types studied.
“the ERAP2 peak eQTL (rs2548540), which was also a lead GWAS SNP for multiple autoimmune diseases, caused genotype-dependent expression differences across all the immune cell types studied”
Quote in the paperSubstantial claim - Findingown data
Two genes in the CD96 locus, CD96 and ZBED2, showed strong cis-eQTLs exclusively in naïve B cells.
“two genes in the CD96 locus that showed strong cis-eQTLs exclusively in naïve B cells”
Quote in the paperNot a substantial claim - Findingown data
4,602 transcripts showed highly cell-specific expression patterns.
“4,602 transcripts showed highly cell-specific expression patterns”
Quote in the paperNot a substantial claim - Findingown data
Additional cis-eQTLs for more than 1,300 genes were identified exclusively in activated naïve CD4+ and/or CD8+ T cells.
“We identified additional cis-eQTLs for >1,300 genes exclusively in activated naïve CD4+ and/or CD8+ T cells”
Quote in the paperSubstantial claim - Findingown data
For each of eight CD4+ T cell subsets, more than 2,000 eGenes were identified, ranging from 2,381 to 3,560 eGenes per cell type.
“we identified >2,000 eGenes (ranging from 2,381 to 3,560 eGenes/cell type, Fig. 4B) for each of the eight CD4+ T cell subsets”
Quote in the paperSubstantial claim - Findingown data
The cell specificity of SNP associations was not entirely due to cell-specific expression of eGenes; associations were observed even for genes expressed at similar levels across multiple cell types.
“The cell specificity of SNPs’ association was not entirely due to cell-specific expression of eGenes, as these associations were observed even for genes that were expressed at similar levels across multiple cell types”
Quote in the paperSubstantial claim - Findingown data
44% of these CD4+ T cell subset eGenes showed a significant cis-association with genotype in only one cell type.
“a large proportion (44%) of these genes showed a significant cis-association with genotype only in one cell type”
Quote in the paperSubstantial claim - Findingown data
Knocking down GAB2 in naïve CD4+ T cells significantly reduced expression of activation markers CD69, CD25, and HLA-DR and cytokine transcripts IFNG and IL2 after anti-CD3 and anti-CD28 stimulation.
“Knocking down GAB2 expression in naïve CD4+ T cells resulted in a significant reduction in the expression of activation markers (CD69, CD25 and HLA-DR) and cytokine transcripts (IFNG and IL2) following anti-CD3 and anti-CD28 stimulation”
Quote in the paperSubstantial claim - Findingown data
The cis-eQTLs were enriched within intronic regions of the genome.
“The cis-eQTLs were enriched within intronic regions of the genome”
Quote in the paperNot a substantial claim - Findingown data
In a time course experiment, a greater proportion of CD4+ T cells expressed cell surface 4-1BB protein in subjects with the TNFRSF9 expression-increasing T/T genotype at rs9657975 compared to those with the C/C genotype.
“we confirmed that following activation, a greater proportion of CD4+ T cells expressed cell surface 4–1BB protein in subjects with the TNFRSF9 (4–1BB) expression-increasing allele (T/T genotype at rs9657975) compared to those with C/C genotype”
Quote in the paperSubstantial claim - Findingown data
The genotype-dependent difference in 4-1BB protein expression was not observed for other activation markers CD69, CD25, or HLA-DR.
“This effect was not observed for other markers of activation such as CD69, CD25 or HLA-DR”
Quote in the paperSubstantial claim - Findingown data
Several cis-eQTLs in the 12p13.2 locus directly overlapped cell-specific DNase sites present in NK cells and naïve CD8+ T cells.
“several of the cis-eQTLs in the 12p13.2 locus directly overlapped many cell-specific DNase sites present in NK cells and naïve CD8+ T cells”
Quote in the paperSubstantial claim - Findingown data
The G allele at rs2927561 was associated with increased expression of all five activating NK receptors and two lncRNAs in the 12p13.2 locus.
“The G allele at rs2927561 was associated with increased expression of all five activating NK receptors and two lncRNAs in the locus”
Quote in the paperSubstantial claim - Findingown data
The GAB2 eQTL rs2511162 had inverse effects on GAB2 expression in B cells versus T cells.
“An interesting eQTL (rs2511162) associated with GAB2 showed inverse effects on gene expression in B cells versus T cells”
Quote in the paperSubstantial claim - Findingown data
51% of these eGenes showed a significant cis-association with genotype in only one specific cell type.
“the majority (51%) of these genes showed a significant cis-association with genotype only in one specific cell type”
Quote in the paperSubstantial claim - Findingown data
12% of all cis-eQTLs were located within ±10 kb of the transcription start site.
“12% of all cis-eQTLs were located within ±10 kb of the TSS”
Quote in the paperNot a substantial claim - Findingown data
ENTPD1, encoding CD39, was an eGene specific to CD4+ memory and TREG subsets.
“A noteworthy example of an eGene specific to the CD4+ memory and TREG subsets was ENTPD1 that encodes for CD39”
Quote in the paperNot a substantial claim - Findingown data
NAB1 knockdown reduced IFN-γ release when NK cells were activated by co-culture with MHC-devoid K-562 cancer cells.
“NAB1 knockdown also reduced IFN-γ release when NK cells were activated by co-culture with MHC devoid K-562 cancer cells”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
Homozygosity for the GA allele of rs149612031 was associated with lack of expression of CD96 and ZBED2 transcripts in B cells but not in NK cells or T cells.
“Homozygosity of the GA allele of rs149612031 (64% of our subjects) was associated with lack of expression of the CD96 and ZBED2 transcripts in B cells but not in other cell types such as NK cells and T cells”
Quote in the paperSubstantial claim - Findingown data
T cell subsets showed an association between RP11-77C3.3 and a SNP linked to Type 1 diabetes.
“T cell subsets an association between RP11–77C3.3 and a SNP linked to Type 1 diabetes”
Quote in the paperNot a substantial claim - Findingcitation
rs12936231, a variant associated with several autoimmune diseases and asthma, modulated expression of ORMDL3 and GSDMB in lymphocyte subsets but not in myeloid cells.
“rs12936231, a variant associated with several autoimmune diseases and asthma, whose functional effects have been previously described (Schmiedel et al., 2016), is associated with the modulation of expression of ORMDL3 and GSDMB in lymphocyte subsets and not in cells of myeloid origin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schmiedel et al., 2016 source
Not checked in the free run.
- Findingown data
37% of all cis-eQTLs were located more than 100 kb from the transcription start site of the target gene.
“37% of all cis-eQTLs were located >100 kb from the TSS of the target gene”
Quote in the paperNot a substantial claim - Findingown data
For each of six common cell types, more than 2,000 eGenes were identified, ranging from 2,421 to 3,590 eGenes per cell type.
“We identified >2,000 eGenes (ranging from 2,421 to 3,590 eGenes/cell type) for each of the indicated six common cell types”
Quote in the paperSubstantial claim - Findingown data
Knocking down SYNGR1 impacted cytokine production by activated NK cells.
“Knocking down SYNGR1 also impacted cytokine production by activated NK cells”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
A dense haploblock of about 240 kb at 12p13.2 contained NK cell- and CD8+ T cell-specific cis-eQTLs associated with three lncRNAs and six C-type lectin-like receptors, including five activating NK receptors and one inhibitory receptor.
“A ~240 kb dense haploblock of NK cell- and CD8+ T cell-specific cis-eQTLs at the 12p13.2 locus was associated with the expression of three lncRNAs and six C-type lectin-like receptors, including 5 activating NK receptors (KLRK1, KLRC4-KLRK1, KLRC4, KLRC3, KLRC2) and an inhibitory receptor (KLRC1)”
Quote in the paperSubstantial claim - Findingown data
Reducing NAB1 expression in NK cells significantly reduced the release of pro-inflammatory cytokines and chemokines IFN-γ, MIP-1β, RANTES, and TNF by human NK cells activated by IgG crosslinking.
“We found that reducing NAB1 expression in NK cells significantly reduced the release of pro-inflammatory cytokines/chemokines such as IFN-γ, MIP-1β, RANTES and TNF by human NK cells activated by IgG crosslinking”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
LACC1 knockdown in CD4+ T cells significantly reduced activation, measured by CD25 and HLA-DR surface expression, and expression of cytokine transcripts IFNG and IL2 following TLR1/2 co-stimulation and CD3/CD28 stimulation.
“We found that LACC1 knockdown in CD4+ T cells when compared to control siRNA treatment resulted in significantly reduced activation (CD25 and HLA-DR surface expression) and expression of cytokine transcripts (IFNG and IL2) following TLR1/2 co-stimulation and CD3/CD28 stimulation”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
IRAK3 had a peak cis-eQTL, rs1732886, only in naïve B cells even though it was expressed at higher levels in classical and non-classical monocytes.
“IRAK3 showed a peak cis-eQTL (rs1732886, adj. association P = 6.82 × 10−17) only in naïve B cells even though it was expressed at even higher levels in classical and non-classical monocytes”
Quote in the paperNot a substantial claim - Findingown data
About 19% of all eGenes identified in each human immune cell type, comprising 2,297 unique GWAS eGenes and 599 to 987 eGenes per cell type, were also associated with GWAS SNPs.
“about 19% of all the eGenes identified in each human immune cell type (2,297 unique GWAS eGenes; 599 to 987 eGenes/cell type) were also associated with GWAS SNPs”
Quote in the paperSubstantial claim- Rests on an assumption: Overlap between GWAS SNPs and eQTLs indicates that the disease risk variant modulates expression of the linked gene in the susceptible cell type.
- Findingown data
LACC1 was upregulated more than 10-fold following activation of T cells.
“we observed that LACC1 was upregulated more than 10-fold following activation of T cells”
Quote in the paperSubstantial claim - Findingown data
Differential gene expression analysis among CD4+ T cell subsets found over 700 genes enriched for expression in one specific CD4+ T cell subset.
“Differential gene expression analysis among the CD4+ T cell subsets revealed over 700 genes that were enriched for expression in one specific CD4+ T cell subset”
Quote in the paperSubstantial claim - Findingown data
For about 36% of the GWAS-associated eGenes, associations were observed in only one or two cell types.
“for about 36% of the eGenes associations were observed in only one or two cell types”
Quote in the paperSubstantial claim - Findingown data
NK cells displayed highly significant eQTLs associated with the lncRNAs RP11-973H7.1 and RP11-305L7.1.
“NK cells displayed highly significant eQTLs associated with the lncRNAs RP11–973H7.1 and RP11–305L7.1”
Quote in the paperSubstantial claim - Findingown data
The paper reports transcripts with sex-biased expression in specific immune cell types.
“Overall, we report on transcripts with sex-biased expression in specific immune cell types”
Quote in the paperSubstantial claim - Findingown data
The stronger female effect of rs1246642 on FAM13A expression was also observed in TH1/17, TH17, and TFH CD4+ T cell subsets.
“This effect was also observed in TH1/17, TH17 and TFH CD4+ T cell subsets”
Quote in the paperSubstantial claim - Findingown data
A CD-risk variant rs528101238 was associated with expression of EDN3 mainly in TH2 cells.
“A CD-risk variant (rs528101238) was associated with expression of EDN3, encoding for endothelin 3, mainly in TH2 cells”
Quote in the paperNot a substantial claim - Findingown data
93% of the sex-biased transcripts were transcribed from autosomes.
“of which 93% were transcribed from autosomes”
Quote in the paperNot a substantial claim - Findingown data
TFH cells showed a prominent association for the eGene TSPAN32, which is linked to chronic lymphocytic leukemia.
“TFH cells that play an important role in ‘helping’ B cell responses showed a prominent association for an eGene (TSPAN32) linked to a B cell malignancy (chronic lymphocytic leukemia, CLL).”
Quote in the paperNot a substantial claim - Findingown data
FAM13A knockdown most significantly reduced IL22 transcript level compared to control siRNA treatment.
“We found that IL22 transcript level was most significantly reduced in FAM13A knock down conditions compared to control siRNA treatment”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
FAM13A was expressed at higher levels in naïve CD4+ T cells of female subjects.
“FAM13A (family with sequence similarity 13 gene) was expressed at higher levels in the naïve CD4+ T cells of female subjects.”
Quote in the paperSubstantial claim - Findingown data
In classical monocytes alone, over 50 transcripts linked to the interferon pathway, including IL6, TNF, and CXCL10, displayed sex-biased expression, with enhanced expression prominent in some female subjects.
“in classical monocytes alone, over 50 transcripts linked to the interferon pathway, including inflammatory cytokines and chemokines like IL6, TNF, CXCL10, displayed sex-biased expression, and enhanced expression was very prominent in some female subjects”
Quote in the paperSubstantial claim - Findingown data
PTGER2 displayed one of the most significant female-biased increased expression patterns, specifically in naïve and memory T cell subsets.
“PTGER2, which encodes the prostaglandin receptor E2 (EP2), displayed one of the most significant female-biased increased expression patterns, specifically in naïve and memory T cell subsets”
Quote in the paperSubstantial claim - Findingown data
FAM13A knockdown significantly reduced the proportion of IL-22 producing memory CD4+ T cells at the protein level.
“We then independently confirmed at the protein level a significant reduction in the proportion of IL-22 producing memory CD4+ T cells following FAM13A knockdown”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Findingown data
Ingenuity pathway analysis predicted interferons type 1 and type 2, interferon regulatory factors, toll-like receptors, and TLR ligands as upstream regulators of sex-biased transcripts.
“Interferons (type 1 and type 2), interferon regulatory factors (IRFs), toll-like receptors (TLRs), and TLR ligands were also predicted by Ingenuity pathway analysis (IPA) to be upstream regulators of sex-biased transcripts”
Quote in the paperSubstantial claim - Findingown data
More than 72% of the sex-biased transcripts showed pronounced sex-biased expression in only a single immune cell type.
“The majority (>72%) of these transcripts showed pronounced sex-biased expression pattern in only a single immune cell type”
Quote in the paperSubstantial claim - Findingown data
NLRP2 showed female-biased expression.
“We also found female-biased expression of NLRP2”
Quote in the paperNot a substantial claim - Findingown data
Independent pathway analysis of female-biased transcripts for each cell type revealed enrichment of genes encoding products involved in canonical interferon and pattern recognition receptor pathways.
“Independent pathway analysis of female-biased transcripts for each cell type revealed enrichment of genes encoding products involved in the canonical interferon and pattern recognition receptor pathways”
Quote in the paperSubstantial claim - Findingown data
Differential gene expression analysis between sexes, considering ancestry and age as covariates, identified 1,875 unique transcripts differentially expressed between sexes across all cell types investigated.
“we performed differential gene expression (DE) analysis between sexes considering ancestry and age as covariates. 1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs, were differentially expressed between sexes (‘sex-biased transcripts’) across all the cell types investigated in this study”
Quote in the paperSubstantial claim - Interpretationown data
The distant location of many cis-eQTLs suggests that genetic variants may correlate with expression of more distant target genes.
“suggesting that genetic variants may correlate with expression of more distant target genes.”
Quote in the paperNot a substantial claim - Interpretationown data
If the G allele at rs2927561 is causally linked to gene expression, it is likely to confer NK cells with enhanced activation potential.
“which suggested that this allele, if causally linked to gene expression, is likely to confer NK cells with an enhanced activation potential”
Quote in the paperNot a substantial claim - Interpretationown data
FAM13A is a positive regulator of IL-22 production by memory CD4+ T cells.
“Our results suggested that FAM13A is a positive regulator of IL-22 production by memory CD4+ T cells”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Interpretationreasoning
Genotype-dependent perturbations in the expression of several genes involved in human TREG function are likely to impact autoimmune disease pathogenesis.
“Our results suggested that genotype-dependent perturbations in the expression patterns of several important genes involved in human TREG function is likely to have an impact on autoimmune disease pathogenesis.”
Quote in the paperSubstantial claim - Interpretationreasoning
Females with higher FAM13A expression are likely to have more pronounced IL-22 responses in vivo.
“and thus females with higher expression of FAM13A are likely to have more pronounced IL-22 responses in vivo”
Quote in the paperSubstantial claim- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
- Study design and conductown data
Standard PCA and multidimensional scaling showed no batch effects in the RNA-Seq data.
“We observed no batch effects by standard principal component analysis and multidimensional scaling analysis.”
Quote in the paperNot a substantial claim - Interpretationown data
The effects of disease risk alleles may not necessarily be most prominent in the cell type in which the associated gene is most highly expressed.
“Overall, these examples show that the effects of disease risk alleles may not necessarily be most prominent in the cell type in which the associated gene is most highly expressed.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 17
- May combine two claims. 18
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAbout 18% of the detected transcripts were long noncoding RNAs.
“About 18% of these transcripts were long-noncoding RNAs (lncRNAs)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMost transcripts were detected in multiple cell types, but their relative abundance varied substantially, producing distinct clustering patterns of different cell types.
“Though a majority of transcripts were detected in multiple cell types (Fig. S1H,I), their relative abundance varied substantially, resulting in distinct clustering patterns of different cell types”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe PBC-risk variant rs74804869 influenced SYNGR1 expression in NK cells and also CD8+ T cells.
“The PBC-risk variant rs74804869 influenced SYNGR1 expression in NK and also CD8+ T cells”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataeQTL analysis of CD4+ memory and TREG subsets yielded over 7,800 eGenes, of which more than 2,500 were unique to these subsets.
“Our eQTL analysis of CD4+ memory and TREG subsets yielded over 7,800 eGenes, of which >2,500 were unique to these subsets”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Crohn's disease-risk variant rs9567293C/C was associated with reduced LACC1 expression in CD4+ memory T cell subsets and in resting and activated naïve T cells, but not in monocytes.
“the CD-risk variant (rs9567293C/C) was associated with reduced expression of LACC1 in CD4+ memory T cell subsets, as well as in resting and activated naïve T cells but not in monocytes”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNAB1 displayed a prominent genotype-dependent association, rs13028201, only in NK cells, although it was widely expressed across all other immune cell types studied.
“we found that the expression of NAB1 displayed prominent genotype-dependent association (rs13028201, adj. P = 1.41 × 10−14) only in NK cells”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCCNG2 had a peak eQTL, rs4859751, specifically in TH1/17 and TH17 cells although it was also highly expressed in other TH subsets and immune cell types.
“CCNG2, encoding for a cell cycle protein, cyclin G2, showed a peak eQTL (rs4859751) specifically in TH1/17 and TH17 cells although it was also highly expressed in other TH subsets and immune cell types”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAn RA-risk variant rs3093026 and a celiac disease-risk variant rs7374671 were associated with expression of CCR6 and CCR2, respectively, in TH1/17 and TH17 subsets.
“an RA-risk variant (rs3093026) and celiac disease-risk variant (rs7374671) that were associated with expression of chemokine receptor genes CCR6 and CCR2, respectively, in TH1/17 and TH17 subsets”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOf the sex-biased transcripts, 1,553 were protein-coding and 196 were lncRNAs.
“1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs, were differentially expressed between sexes”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe cis-eQTL rs1246642 had a stronger impact on FAM13A expression in female subjects; homozygous CC versus TT females had 3.5-fold greater FAM13A transcript levels compared to a less than 1.5-fold increase in males.
“We also found a cis-eQTL (rs1246642) whose impact on expression was stronger in female subjects (Fig. 6F,G and Fig. S6B,C); homozygous females carrying the CC versus TT genotype had 3.5-fold greater levels of FAM13A transcripts compared to a <1.5-fold increase in males.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTREG cells were most susceptible to the effects of several autoimmune disease-risk variants, with notable eGenes including IKZF4, PDE4A, and PTGIR.
“TREG cells were most susceptible to the effects of several autoimmune disease-risk variants. Notable eGenes associated with these variants include IKZF4, PDE4A and PTGIR”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPBC-risk variants that modulate NAB1 and SYNGR1 expression are likely to impact NK cell function and influence PBC disease susceptibility.
“Together, these results suggested that PBC-risk variants that modulate NAB1 and SYNGR1 expression are likely to impact NK cell function and influence PBC disease susceptibility.”
Quote in the paperSubstantial claim- Rests on an assumption: Overlap between GWAS SNPs and eQTLs indicates that the disease risk variant modulates expression of the linked gene in the susceptible cell type.
- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
Classified as probably not a substantial claim.
Study design and conductown dataThe identity of each RNA-Seq sample was confirmed by matching genotype data from the same subject via genome-wide SNP analysis of exonic regions.
“The identity of all individual RNA-Seq samples was confirmed by cross-comparison with genotyping data for a given subject by genome-wide analysis of SNPs overlapping exons.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningSamples for each cell type were processed in a single RNA-Seq batch to prevent experimental batch effects.
“Further, samples from each specific cell types were processed for RNASeq in one batch to avoid any experimental batch effects.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the analysis of sex-biased transcripts, ancestry and age were included as covariates.
“Sex-biased transcripts were identified by performing pairwise comparison (female (n = 37) versus male (n = 54) subjects) using DESeq2 and considering ancestry and age as covariates; we considered a transcript expressed differentially when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. P value of < 0.05.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThe first two principal components of genotype data were included as covariates to reduce possible ancestry differences among samples.
“The first two principal components of the genotyping data were used as covariates to minimize possible differences introduced by the different ancestry in the samples.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study received approval from the institutional review board at the La Jolla Institute for Allergy and Immunology under protocol SGE-121-0714.
“The Institutional Review Board (IRB) of the La Jolla Institute for Allergy and Immunology (LJI; IRB protocol no. SGE-121–0714) approved the study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationRNA-Seq expression data were regularized-log transformed and quantile-normalized to reduce the influence of possible outliers.
“To diminish the effects of possible outliers, the regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized.”
- Also stated in: § Genotyping, imputation and determination of Eqtl · plain
“The regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized to diminish the effects of possible outliers.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Love et al., 2014 source
Not checked in the free run.
- Also stated in: § Genotyping, imputation and determination of Eqtl · plain
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationLow-quality SNPs were removed: those failing in more than 5% of samples and those with Illumina GC scores below 0.2 in more than 10% of samples were filtered out.
“The data quality was assessed using the snpQC package (Gondro et al., 2014) for R v3.2.3 (http://www.R-project.org) and low-quality SNPs were removed for downstream analysis: SNPs failing in more than 5% of the samples and SNPs with Illumina’s GC scores less than 0.2 in more than 10% of the samples were filtered out.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gondro et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationThe PheGenI dataset used for GWAS SNP analysis contained 14,321 significant SNP-trait associations (P < 5 × 10−8) and 846 distinct phenotypes.
“To define the collection of SNPs from GWAS studies, we downloaded the dataset of the Phenotype-Genotype Integrator (PheGenI) (Ramos et al., 2014), which merges NHGRI GWAS Catalog data with several databases of the National Center for Biotechnology Information (NCBI), including Gene, dbGaP, OMIM, eQTL and dbSNP (September 2017; https://www.ncbi.nlm.nih.gov/gap/phegeni).”
- Also stated in: § GWAS SNP database construction and analysis · plain
“the resulting catalog of SNP-trait associations included 14,321 significant associations (lead GWAS SNPs; defined as P < 5 × 10−8) and 846 distinct phenotypes/traits.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ramos et al., 2014 source
Not checked in the free run.
- Also stated in: § GWAS SNP database construction and analysis · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTranscripts whose mean TPM was under 1.0 in every sample of a cell type were removed.
“Transcripts with mean TPM < 1.0 across all samples of a given cell type were excluded from the analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe products of autoimmune risk-eGenes PDE4A and PTGIR are likely to modulate cAMP-mediated immunoregulation and influence disease pathogenesis.
“Thus, the products of autoimmune risk-eGenes PDE4A and PTGIR are likely to modulate cAMP-mediated immunoregulation and influence disease pathogenesis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe eQTL analysis excluded the pseudoautosomal regions of chromosomes X and Y, reducing the number of annotated transcripts analyzed from 57,820 to 57,215 (605 genes missing).
“Notably, the eQTL analysis did not cover the pseudoautosomal regions of chr X or chr Y, thereby slightly lowering the annotated transcript count from 57,820 to 57,215 (605 missing genes).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenFor eQTL analysis, SNPs missing in more than 5% of samples or with minor allele frequency below 5% were excluded.
“SNPs missing for more than 5% of the samples or with a minimum allele frequency (MAF) lower than 5% were removed from the analysis.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationTranscripts with low expression-the bottom one-third for at least 80% of samples-were filtered out before eQTL analysis.
“Briefly, transcripts with low expression values – the bottom one-third of all transcripts for at least 80% of the samples – were filtered out.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe cohort comprised 54 male and 37 female subjects with a median age of 27 years (range 18-61).
“The cohort consisted of 54 males and 37 female subjects with a median age of 27 years (range 18 to 61 years).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataSamples that failed quality control were excluded from downstream analysis; 1,544 RNA-Seq samples were included.
“Samples failing any quality control step (RNA quality and quantity, PCR amplification, library fragment size) were eliminated from further downstream steps.”
- Also stated in: § QUANTIFICATION AND STATISTICAL ANALYSIS · plain
“Any samples failing established quality controls (QC) were eliminated from downstream analysis; assay details and QCs on RNA-Seq samples included are provided in Table S1B (1,544 samples in total).”
Quote in the paperNot a substantial claim- Also stated in: § QUANTIFICATION AND STATISTICAL ANALYSIS · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenLibrary preparation was automated on the Biomek FXP platform to reduce assay-to-assay variability.
“Sequencing library preparation steps were performed in a 96-well format, utilizing the automated platform Biomek FXP (Beckman Coulter), to reduce assay-to-assay variability.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataNinety-one healthy volunteers from the San Diego area provided leukapheresis samples at the San Diego Blood Bank after giving written informed consent.
“A total of 91 healthy volunteers were recruited in the San Diego area, who provided leukapheresis samples at the San Diego Blood Bank (SDBB) after written informed consent.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataAll subjects self-reported ethnicity and race and tested negative for hepatitis B, hepatitis C, and HIV.
“All study subjects self-reported ethnicity and race details, and were tested negative for hepatitis B, hepatitis C and human immunodeficiency virus (HIV).”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Overlap between GWAS SNPs and eQTLs indicates that the disease risk variant modulates expression of the linked gene in the susceptible cell type.
“To shed light on the disease relevance of the eQTLs identified in human immune cells, we next focused on the subset of eGenes linked to eQTLs that directly overlapped haploblocks of significant GWAS SNPs”
The paper relies on this without support.
Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
“As a first step in that process, we knocked down these genes in human NK cells and tested their impact on NK cell activity”
The paper relies on this without support.
The 13 immune cell types and activation conditions studied are representative enough of human immune cells to generalize eQTL and sex-biased expression findings.
“The cell types presented here comprise over 60% of all circulating mononuclear cells”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Within the correlated gene sets were genes known to be enriched or functionally important in the memory T cell subset driven by the transcription factor in question, such as IL4R for GATA3 and CTLA4 for both Helios and FOXP3.
“Within these correlated gene sets were genes known to be enriched or functionally important in the memory T cell subset driven by the TF in question, such as IL4R for GATA3 and CTLA4 for both Helios and FOXP324.”
From NEAT-seq: simultaneous profiling of intra-nuclear proteins, chromatin accessibility and gene expression in single cells (2022) · cites this paper as [24]
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464 · see citing works
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247 · see citing works
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,477 · see citing works
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370 · see citing works
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · cited 1× · see citing works
“…large-scale epigenomic initiatives analyzing multiple human cell types have attributed cis-regulatory function to nearly 20% of the non-coding DNA sequences, and showed that disease risk variants are enriched in cell-specific cis-regulatory DNA sequences (Roadmap Epigenomics et al., 2015).”
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378 · see citing works
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062 · see citing works
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992 · see citing works
GENCODE: The reference human genome annotation for The ENCODE Project
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585 · see citing works
Genetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036 · see citing works
Self-citationHowie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928 · see citing works
jvenn: an interactive Venn diagram viewer
Bardou, P., Mariette, J., Escudié, F., Djemiel, C., & Klopp, C. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-293 · Cited by 2,506 · see citing works
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2785 · Cited by 2,443 · see citing works
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425 · see citing works
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
Wagner, G. P., Kin, K., & Lynch, V. J. (2012) · Theory in Biosciences · doi:10.1007/s12064-012-0162-3 · Cited by 2,085 · see citing works
Matrix eQTL: ultra fast eQTL analysis via large matrix operations
Shabalin, A. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts163 · Cited by 1,694 · see citing works
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551 · see citing works
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353 · see citing works
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A., & Kuchroo, V. K. (2013) · Nature · doi:10.1038/nature11984 · Cited by 1,022 · see citing works
SEQC/MAQC-III Consortium (2014) · Nature Biotechnology · doi:10.1038/nbt.2957 · Cited by 983 · see citing works
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H., & Bryceson, Y. T. (2009) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 894 · see citing works
Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression
Fairfax, B. P., Humburg, P., Makino, S., Naranbhai, V., Wong, D., Lau, E., Jostins, L., Plant, K., Andrews, R., McGee, C., et al. (2014) · Science · doi:10.1126/science.1246949 · Cited by 764 · see citing works
Mapping cis- and trans-regulatory effects across multiple tissues in twins
The Multiple Tissue Human Expression Resource (MuTHER) Consortium, Grundberg, E., Small, K. S., Hedman, Å. K., Nica, A. C., Buil, A., Keildson, S., Bell, J. T., Yang, T.-P., Meduri, E., et al. (2012) · Nature Genetics · doi:10.1038/ng.2394 · Cited by 729 · see citing works
Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells
Chen, L., Ge, B., Casale, F. P., Vasquez, L., Kwan, T., Garrido-Martín, D., Watt, S., Yan, Y., Kundu, K., Ecker, S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.026 · Cited by 679 · see citing works
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., et al. (2014) · Science · doi:10.1126/science.1249547 · Cited by 506 · see citing works
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
Chester, C., Sanmamed, M. F., Wang, J., & Melero, I. (2018) · Blood · doi:10.1182/blood-2017-06-741041 · Cited by 499 · see citing works
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Chan, C. J., Martinet, L., Gilfillan, S., Souza-Fonseca-Guimarães, F., Chow, M. T., Town, L., Ritchie, D. S., Colonna, M., Andrews, D. M., & Smyth, M. J. (2014) · Nature Immunology · doi:10.1038/ni.2850 · Cited by 488 · see citing works
Genetic adaptation and Neandertal admixture shaped the immune system of human populations
Quach, H., Rotival, M., Pothlichet, J., Loh, Y.-H. E., Dannemann, M., Zidane, N., Laval, G., Patin, E., Harmant, C., Lopez, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.024 · Cited by 475 · see citing works
Boniface, K., Bak‐Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & Malefyt, R. D. W. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 474 · see citing works
Matrix eQTL: Ultra fast eQTL analysis via large matrix operationsPreprint
Shabalin, A. A. (2011) · arXiv (Cornell University) · doi:10.17615/g28n-r219 · Cited by 452 · see citing works
Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells
Lee, M. N., Ye, C., Villani, A.-C., Raj, T., Li, W., Eisenhaure, T. M., Imboywa, S. H., Chipendo, P. I., Ran, F. A., Slowikowski, K., et al. (2014) · Science · doi:10.1126/science.1246980 · Cited by 441 · see citing works
Identification of context-dependent expression quantitative trait loci in whole blood
Zhernakova, D. V., Deelen, P., Vermaat, M., van Iterson, M., van Galen, M., Arindrarto, W., van 't Hof, P., Mei, H., van Dijk, F., Westra, H.-J., et al. (2017) · Nature Genetics · doi:10.1038/ng.3737 · Cited by 441 · see citing works
Heritability and genomics of gene expression in peripheral blood
Wright, F. A., Sullivan, P. F., Brooks, A. I., Zou, F., Sun, W., Xia, K., Madar, V., Jansen, R., Chung, W., Zhou, Y.-H., et al. (2014) · Nature Genetics · doi:10.1038/ng.2951 · Cited by 362 · see citing works
Cho, M. H., McDonald, M., Zhou, X., Mattheisen, M., Castaldi, P. J., Hersh, C. P., DeMeo, D. L., Sylvia, J. S., Ziniti, J. P., Laird, N. M., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70002-5 · Cited by 348 · see citing works
Guttman-Yassky, E., Brunner, P. M., Neumann, A. U., Khattri, S., Pavel, A. B., Malik, K., Singer, G. K., Baum, D., Gilleaudeau, P., Sullivan-Whalen, M., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.01.016 · Cited by 343 · see citing works
Eos Mediates Foxp3-Dependent Gene Silencing in CD4 + Regulatory T Cells
Pan, F., Yu, H., Dang, E. V., Barbi, J. J., Pan, X., Grosso, J. F., Jinasena, D., Sharma, S. M., McCadden, E., Getnet, D., et al. (2009) · Science · doi:10.1126/science.1176077 · Cited by 335 · see citing works
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
Bacher, P., Heinrich, F., Stervbo, U., Nienen, M., Vahldieck, M., Iwert, C., Vogt, K., Kollet, J., Babel, N., Sawitzki, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.050 · Cited by 319 · see citing works
Ramos, E. M., Hoffman, D., Junkins, H. A., Maglott, D., Phan, L., Sherry, S. T., Feolo, M., & Hindorff, L. A. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.96 · Cited by 231 · see citing works
Guidance for RNA-seq co-expression network construction and analysis: safety in numbers
Ballouz, S., Verleyen, W., & Gillis, J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv118 · Cited by 215 · see citing works
Regulation of the T Cell Response by CD39
Takenaka, M. C., Robson, S. C., & Quintana, F. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.009 · Cited by 203 · see citing works
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes
Mannino, D. M., Aryal, S., & Diaz‐Guzman, E. (2014) · International Journal of COPD · doi:10.2147/copd.s54476 · Cited by 199 · see citing works
Wehbi, V. L., & Taskén, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00222 · Cited by 182 · see citing works
Sharma, M. D., Huang, L., Choi, J.-H., Lee, E.-J., Wilson, J. M., Lemos, H. D. P., Pan, F., Blazar, B. R., Pardoll, D. M., Mellor, A. L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.013 · Cited by 180 · see citing works
C13orf31 (FAMIN) is a central regulator of immunometabolic function
Cader, M. Z., Boroviak, K., Zhang, Q., Assadi, G., Kempster, S. L., Sewell, G. W., Saveljeva, S., Ashcroft, J., Clare, S., Mukhopadhyay, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3532 · Cited by 168 · see citing works
Hakonarson, H. H., Qu, H., Bradfield, J. P., Marchand, L., Kim, C., Glessner, J., Grabs, R., Casalunovo, T., Taback, S. P., Frackelton, E. C., et al. (2008) · Diabetes · doi:10.2337/db07-1305 · Cited by 150 · see citing works
17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells
Schmiedel, B. J., Seumois, G., Samaniego-Castruita, D., Cayford, J., Schulten, V., Chavez, L., Ay, F., Sette, A., Peters, B., & Vijayanand, P. (2016) · Nature Communications · doi:10.1038/ncomms13426 · Cited by 127 · see citing works
Self-citationZhang, L., Cheng, Z., Liu, W., & Wu, K. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.770456 · Cited by 98 · see citing works
Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma
Seumois, G., Zapardiel‐Gonzalo, J., White, B. M., Singh, D. K., Schulten, V. M. J., Dillon, M., Hinz, D., Broide, D. H., Sette, A., Peters, B., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600397 · Cited by 92 · see citing works
Self-citationTarrant, J. M., Groom, J. R., Metcalf, D., Li, R., Borobokas, B., Wright, M. D., Tarlinton, D. M., & Robb, L. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5006-5018.2002 · Cited by 78 · see citing works
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes
Aryal, S. R., Diaz‐Guzman, E., & Mannino, D. M. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 78 · see citing works
IRAK-M Regulation and Function in Host Defense and Immune Homeostasis
Hubbard, L. L. N., & Moore, B. B. (2010) · Infectious Disease Reports · doi:10.4081/idr.2010.e9 · Cited by 77 · see citing works
Lahiri, A., Hedl, M., Yan, J., & Abraham, C. (2017) · Nature Communications · doi:10.1038/ncomms15614 · Cited by 76 · see citing works
NOD‐like receptors interfacing the immune and reproductive systems
Gorp, H. V., Kuchmiy, A., Hauwermeiren, F. V., & Lamkanfi, M. (2014) · The FEBS Journal · doi:10.1111/febs.13014 · Cited by 70 · see citing works
Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases
Rostamzadeh, D., Kazemi, T., Amirghofran, Z., & Shabani, M. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1472768 · Cited by 68 · see citing works
Emerging Roles for the FCRL Family Members in Lymphocyte Biology and Disease
Li, F. J., Won, W.-J., Becker, E., Easlick, J. L., Tabengwa, E. M., Li, R., Shakhmatov, M. A., Honjo, K., Burrows, P. D., & Davis, R. S. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_2 · Cited by 60 · see citing works
Sivasankar, B., Longhi, M. P., Gallagher, K. M. E., Betts, G. J., Morgan, B. P., Godkin, A. J., & Gallimore, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804243 · Cited by 53 · see citing works
Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation
Liu, W., Li, H., Zhang, X., Wen, D., Feng, Y., Yang, S., Jia, X., Cong, B., & Ma, C. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.08.006 · Cited by 34 · see citing works
Gondro, C., Porto‐Neto, L. R., & Lee, S. H. (2014) · Animal Genetics · doi:10.1111/age.12198 · Cited by 34 · see citing works
Association of Lung Function Genes with Chronic Obstructive Pulmonary Disease
Kim, W. J., Lim, M.-N., Hong, Y., Silverman, E. K., Lee, J., Jung, B. H., Won, S. H., Choi, H. S., Jung, Y. J., Park, Y. B., et al. (2014) · Lung · doi:10.1007/s00408-014-9579-4 · Cited by 34 · see citing works
Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression
Wolkers, M. C., Gerlach, C., Arens, R., Janssen, E. M., Fitzgerald, P., Schumacher, T. N., Medema, J. P., Green, D. R., & Schoenberger, S. P. (2011) · Blood · doi:10.1182/blood-2011-08-373910 · Cited by 30 · see citing works
A Sensitive and Integrated Approach to Profile Messenger RNA from Samples with Low Cell Numbers
Rosales, S. L., Liang, S. Y., Engel, I., Schmiedel, B. J., Kronenberg, M., Vijayanand, P., & Seumois, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7896-0_21 · Cited by 30 · see citing works
Self-citationEfficient T‐cell priming and activation requires signaling through prostaglandin E2 (EP) receptors
Sreeramkumar, V., Hons, M., Punzón, C., Stein, J. V., Sancho, D., Fresno, M., & Cuesta, N. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.62 · Cited by 22 · see citing works
Endothelin regulates function of IL-17-producing T cell subset
Tanaka, K., Yoshioka, K., Tatsumi, K., Kimura, S., & Kasuya, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.084 · Cited by 21 · see citing works
Deng, J., Sham, P. C., & Li, M. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.021832 · Cited by 19 · see citing works
Osinalde, N., Sánchez‐Quiles, V., Blagoev, B., & Kratchmarova, I. (2016) · Scientific Reports · doi:10.1038/srep23530 · Cited by 11 · see citing works
Bloodworth, M. H., Goleniewska, K., & Peebles, R. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1021 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The gasdermins, a protein family executing cell death and inflammation
Broz, P., Pelegrín, P., & Shao, F. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0228-2 · Cited by 1,641 · see citing works
Considering how biological sex impacts immune responses and COVID-19 outcomes
Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0348-8 · Cited by 925 · see citing works
Deciphering miRNAs’ Action through miRNA Editing
de Sousa, M. C., Gjorgjieva, M., Dolicka, D., Sobolewski, C., & Foti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246249 · Cited by 823 · see citing works
A cell atlas of human thymic development defines T cell repertoire formation
Park, J.-E., Botting, R. A., Conde, C. D., Popescu, D.-M., Lavaert, M., Kunz, D. J., Goh, I., Stephenson, E., Ragazzini, R., Tuck, E. J., et al. (2020) · Science · doi:10.1126/science.aay3224 · Cited by 725 · see citing works
Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease
Yazar, S., Alquicira-Hernandez, J., Wing, K., Senabouth, A., Gordon, M. G., Andersen, S., Lu, Q., Rowson, A., Taylor, T. R. P., Clarke, L., et al. (2022) · Science · doi:10.1126/science.abf3041 · Cited by 682 · see citing works
The impact of sex on gene expression across human tissues
Oliva, M., Muñoz-Aguirre, M., Kim-Hellmuth, S., Wucher, V., Gewirtz, A. D., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A., et al. (2020) · Science · doi:10.1126/science.aba3066 · Cited by 679 · see citing works
A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
Uhlen, M., Karlsson, M. J., Zhong, W., Tebani, A., Pou, C., Mikes, J., Lakshmikanth, T., Forsström, B., Edfors, F., Odeberg, J., et al. (2019) · Science · doi:10.1126/science.aax9198 · Cited by 594 · see citing works
Interferon-γ: teammate or opponent in the tumour microenvironment?
Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00566-3 · Cited by 587 · see citing works
Sexual-dimorphism in human immune system aging
Márquez, E. J., Chung, C.-H., Marches, R., Rossi, R. J., Nehar-Belaid, D., Eroglu, A., Mellert, D. J., Kuchel, G. A., Banchereau, J., & Ucar, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14396-9 · Cited by 584 · see citing works
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19
Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Kusnadi, A., Simon, H. A., Eschweiler, S., Grifoni, A., Pelosi, E., Weiskopf, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.001 · Cited by 565 · see citing works
Self-citationSchwartzentruber, J., Cooper, S., Liu, J. Z., Barrio-Hernandez, I., Bello, E., Kumasaka, N., Young, A. M. H., Franklin, R. J. M., Johnson, T., Estrada, K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00776-w · Cited by 532 · see citing works
A compendium of uniformly processed human gene expression and splicing quantitative trait loci
Kerimov, N., Hayhurst, J. D., Peikova, K., Manning, J. R., Walter, P., Kolberg, L., Samoviča, M., Sakthivel, M. P., Kuzmin, I., Trevanion, S. J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00924-w · Cited by 440 · see citing works
Hautakangas, H. M., Winsvold, B. S., Ruotsalainen, S., Björnsdóttir, G., Harder, A. V. E., Kogelman, L. J. A., Thomas, L. F., Noordam, R., Benner, C., Gormley, P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-00990-0 · Cited by 402 · see citing works
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Ota, M., Nagafuchi, Y., Hatano, H., Ishigaki, K., Terao, C. C., Takeshima, Y., Yanaoka, H., Kobayashi, S., Okubo, M., Shirai, H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.056 · Cited by 322 · see citing works
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Dong, M. B., Wang, G., Chow, R. D., Ye, L., Zhu, L., Dai, X., Park, J. J., Kim, H. R., Errami, Y., Guzman, C. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.044 · Cited by 330 · see citing works
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Schmidt, R., Steinhart, Z., Layeghi, M., Freimer, J. W., Bueno, R., Nguyen, V., Blaeschke, F., Ye, C. J., & Marson, A. (2022) · Science · doi:10.1126/science.abj4008 · Cited by 285 · see citing works
Robertson, C. C., Inshaw, J. R. J., Onengut-Gumuscu, S., Chen, W.-M., Santa Cruz, D. F., Yang, H., Cutler, A. J., Crouch, D. J. M., Farber, E., Bridges, S. L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00880-5 · Cited by 302 · see citing works
Bryois, J., Calini, D., Macnair, W., Foo, L., Urich, E., Ortmann, W., Iglesias, V. A., Selvaraj, S., Nutma, E., Marzin, M., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01128-z · Cited by 311 · see citing works
Where Are the Disease-Associated eQTLs?
Umans, B. D., Battle, A., & Gilad, Y. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.08.009 · Cited by 296 · see citing works
GOnet: a tool for interactive Gene Ontology analysis
Pomaznoy, M., Ha, B., & Peters, B. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2533-3 · Cited by 299 · see citing works
Self-citationMechanisms and consequences of sex differences in immune responses
Dunn, S. E., Perry, W. A., & Klein, S. L. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00787-w · Cited by 255 · see citing works
The Human Protein Atlas—Spatial localization of the human proteome in health and disease
Digre, A., & Lindskog, C. (2020) · Protein Science · doi:10.1002/pro.3987 · Cited by 247 · see citing works
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrı́n, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 241 · see citing works
RASA2 ablation in T cells boosts antigen sensitivity and long-term function
Carnevale, J. C., Shifrut, E., Kale, N., Nyberg, W. A., Blaeschke, F., Chen, Y. Y., Li, Z., Bapat, S. P., Diolaiti, M. E., O’Leary, P. C., et al. (2022) · Nature · doi:10.1038/s41586-022-05126-w · Cited by 236 · see citing works
Kusnadi, A., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Meckiff, B. J., Simon, H. A., Pelosi, E., Seumois, G., Ay, F., Vijayanand, P., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe4782 · Cited by 232 · see citing works
Self-citationWebber, B. R., Lonetree, C.-L., Kluesner, M. G., Johnson, M. J., Pomeroy, E. J., Diers, M. D., Lahr, W. S., Draper, G. M., Slipek, N. J., Smeester, B. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13007-6 · Cited by 232 · see citing works
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Friedrich, M., Sankowski, R., Bunse, L., Kilian, M., Green, E., Guevara, C. R., Pusch, S., Poschet, G., Sanghvi, K., Hahn, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00201-z · Cited by 232 · see citing works
Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens
Morris, J. A., Caragine, C., Daniloski, Z., Domingo, J., Barry, T., Lu, L., Davis, K., Ziosi, M., Glinos, D. A., Hao, S., et al. (2023) · Science · doi:10.1126/science.adh7699 · Cited by 208 · see citing works
Single-cell eQTL models reveal dynamic T cell state dependence of disease loci
Nathan, A., Asgari, S., Ishigaki, K., Valencia, C., Amariuta, T., Luo, Y., Beynor, J. I., Baglaenko, Y., Suliman, S., Price, A. L., et al. (2022) · Nature · doi:10.1038/s41586-022-04713-1 · Cited by 217 · see citing works
The conneXion between sex and immune responses
Forsyth, K. S., Jiwrajka, N., Lovell, C. D., Toothacre, N. E., & Anguera, M. C. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00996-9 · Cited by 226 · see citing works
Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma
Seumois, G., Ramírez-Suástegui, C., Schmiedel, B. J., Liang, S. Y., Peters, B., Sette, A., & Vijayanand, P. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba6087 · Cited by 208 · see citing works
Self-citationDissection of intercellular communication using the transcriptome-based framework ICELLNET
Noël, F., Massenet-Regad, L., Carmi-Levy, I., Cappuccio, A., Grandclaudon, M., Trichot, C., Kieffer, Y., Mechta‐Grigoriou, F., & Soumelis, V. (2021) · Nature Communications · doi:10.1038/s41467-021-21244-x · Cited by 205 · see citing works
Sumida, T. S., Cheru, N. T., & Hafler, D. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00994-x · Cited by 208 · see citing works
Ye, L., Park, J. J.-Y., Peng, L., Yang, Q., Chow, R. D.-W., Dong, M. B., Lam, S. Z., Guo, J., Tang, E., Zhang, Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.009 · Cited by 204 · see citing works
Kiryluk, K., Sánchez, E., Zhou, S., Zanoni, F., Liu, L., Mladkova, N., Khan, A., Marasà, M., Zhang, J. Y., Balderes, O., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01422-x · Cited by 209 · see citing works
Functions and regulation of T cell-derived interleukin-10
Neumann, C., Scheffold, A., & Rutz, S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101344 · Cited by 199 · see citing works
Transferrin receptor targeting chimeras for membrane protein degradation
Zhang, D., Duque-Jimenez, J., Facchinetti, F., Brixi, G., Rhee, K., Feng, W. W., Janne, P. A., & Zhou, X. X. (2024) · Nature · doi:10.1038/s41586-024-07947-3 · Cited by 205 · see citing works
Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation
Soskic, B., Cano-Gamez, E., Smyth, D. J., Ambridge, K., Ke, Z., Matte, J. C., Bossini‐Castillo, L., Kaplanis, J., Ramirez-Navarro, L., Lorenc, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01066-3 · Cited by 189 · see citing works
Zhang, Z. S., Luo, K., Zou, Z., Qiu, M., Tian, J., Sieh, L., Shi, H., Zou, Y., Wang, G. T., Morrison, J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0644-z · Cited by 187 · see citing works
He, L., Davila-Velderrain, J., Sumida, T. S., Hafler, D. A., Kellis, M., & Kulminski, A. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02146-6 · Cited by 181 · see citing works
A genome-scale screen for synthetic drivers of T cell proliferation
Legut, M., Gajic, Z. Z., Guarino, M., Daniloski, Z., Rahman, J. A., Xue, X., Lu, C., Lu, L., Mimitou, E. P., Hao, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04494-7 · Cited by 177 · see citing works
Germline genetic contribution to the immune landscape of cancer
Sayaman, R. W., Saad, M., Thórsson, V., Hu, D., Hendrickx, W., Roelands, J. P., Porta‐Pardo, E., Mokrab, Y., Farshidfar, F., Kirchhoff, T., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.011 · Cited by 171 · see citing works
Ha, E., Bae, S., & Kim, K.-W. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219065 · Cited by 177 · see citing works
Griesemer, D. S., Xue, J. R., Reilly, S. K., Ulirsch, J. C., Kukreja, K., Davis, J. R., Kanai, M., Yang, D. K., Butts, J. C., Guney, M. H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.025 · Cited by 173 · see citing works
The missing link between genetic association and regulatory function
Connally, N. J., Nazeen, S., Lee, D., Shi, H., Stamatoyannopoulos, J. A., Chun, S., Cotsapas, C. J., Cassa, C. A., & Sunyaev, S. R. (2022) · eLife · doi:10.7554/elife.74970 · Cited by 144 · see citing works
Role of Interleukin-6 in Vascular Health and Disease
Villar-Fincheira, P., Sanhueza-Olivares, F., Norambuena-Soto, I., Cancino-Arenas, N., Hernandez-Vargas, F., Troncoso, R., Gabrielli, L., & Chiong, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.641734 · Cited by 154 · see citing works
Ostendorf, T., Zillinger, T., Andryka, K., Schlee-Guimaraes, T. M., Schmitz, S. R., Marx, S., Bayrak, K., Linke, R., Salgert, S., Wegner, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.009 · Cited by 150 · see citing works
Zheng, Z., Huang, D., Wang, J., Zhao, K., Zhou, Y., Guo, Z., Zhai, S., Xu, H., Cui, H. S., Yao, H., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz888 · Cited by 138 · see citing works
Chen, A. F., Parks, B., Kathiria, A. S., Ober-Reynolds, B., Goronzy, J. J., & Greenleaf, W. J. (2022) · Nature Methods · doi:10.1038/s41592-022-01461-y · Cited by 139 · see citing works
Stapleton, F. J., Argüeso, P., Asbell, P. A., Azar, D. T., Bosworth, C. F., Chen, W., Ciolino, J. B., Craig, J. P., Gallar, J., Galor, A., et al. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.05.040 · Cited by 139 · see citing works
Single-cell genomics meets human genetics
Cuomo, A. S. E., Nathan, A., Raychaudhuri, S., MacArthur, D. G., & Powell, J. E. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00599-5 · Cited by 124 · see citing works
Budu‐Aggrey, A., Kilanowski, A., Sobczyk, M., Shringarpure, S., Mitchell, R. E., Reis, K., Reigo, A., Mägi, R., Nelis, M., Tanaka, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41180-2 · Cited by 135 · see citing works
Considerations for designing preclinical cancer immune nanomedicine studies
Jiang, W., Wang, Y., Wargo, J. A., Lang, F. F., & Kim, B. Y. S. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-00817-9 · Cited by 132 · see citing works
Abbas, H. A., Hao, D., Tomczak, K. J., Barrodia, P., Im, J. S., Reville, P. K., Alaniz, Z., Wang, W., Wang, R., Wang, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26282-z · Cited by 130 · see citing works
Wang, Y., Wang, Y., Luo, W., Huang, L., Xiao, J., Li, F., Qin, S., Song, X., Wu, Y., Zeng, Q., et al. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46695 · Cited by 130 · see citing works
Wang, P., Yao, L., Luo, M., Zhou, W., Jin, X., Xu, Z., Shi, Y., Li, Y., Xu, C., Cheng, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00280-3 · Cited by 123 · see citing works
Promoter-interacting expression quantitative trait loci are enriched for functional genetic variants
Chandra, V., Bhattacharyya, S., Schmiedel, B. J., Madrigal, A., Gonzalez-Colin, C., Fotsing, S., Crinklaw, A., Seumois, G., Mohammadi, P., Kronenberg, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00745-3 · Cited by 123 · see citing works
Self-citationKhatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F. F., Reksten, T. R., Adler, A., Alevizos, I., Anaya, J., Aqrawi, L. A., Baecklund, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30773-y · Cited by 120 · see citing works
Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics
Migliore, L., Nicolì, V., & Stoccoro, A. (2021) · Biomedicines · doi:10.3390/biomedicines9060652 · Cited by 115 · see citing works
Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., et al. (2021) · Brain · doi:10.1093/brain/awab337 · Cited by 111 · see citing works
“OAS1 is expressed by multiple cell types in the myeloid lineage including monocytes, macrophages, and microglia, as well as natural killer cell lymphocytes.(33,81,82,94) Here, we show that rs1131454 within OAS1 is associated with Alzheimer’s disease, and previously we showed that this locus acts as an eQTL regulating…”
BackgroundXu, J., Guo, C., Hermanson, P. J., Xu, Q., Sun, C., Chen, W., Kan, Q., Li, M., Crisp, P. A., Yan, J., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1859-0 · Cited by 115 · see citing works
Renoux, F., Stellato, M., Haftmann, C., Vogetseder, A., Huang, R., Subramaniam, A., Becker, M. O., Błyszczuk, P., Becher, B., Distler, J. H. W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107826 · Cited by 115 · see citing works
The landscape of host genetic factors involved in immune response to common viral infections
Kachuri, L., Francis, S. S., Morrison, M. L., Wendt, G. A., Bossé, Y., Cavazos, T. B., Rashkin, S. R., Ziv, E., & Witte, J. S. (2020) · Genome Medicine · doi:10.1186/s13073-020-00790-x · Cited by 125 · see citing works
NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation
Yu, T., Hou, D., Zhao, J., Lü, X., Greentree, W. K., Zhao, Q. C., Yang, M., Conde, D.-G., Linder, M. E., & Lin, H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114070 · Cited by 111 · see citing works
The X-linked epigenetic regulator UTX controls NK cell-intrinsic sex differences
Cheng, M. I., Li, J. H., Riggan, L., Chen, B., Tafti, R. Y., Chin, S. C., Ma, F., Pellegrini, M. A., Hrncir, H., Arnold, A. P., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01463-8 · Cited by 114 · see citing works
Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self
Chowdhury, R. R., D’Addabbo, J., Huang, X., Veizades, S. A., Sasagawa, K., Louis, D. M., Cheng, P. P., Sokol, J., Jensen, A., Tso, A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320090 · Cited by 107 · see citing works
Circulating T cell-monocyte complexes are markers of immune perturbations
Burel, J. G., Pomaznoy, M., Arlehamn, C. S. L., Weiskopf, D., Antunes, R. D. S., Jung, Y., Babor, M., Schulten, V. M. J., Seumois, G., Greenbaum, J., et al. (2019) · eLife · doi:10.7554/elife.46045 · Cited by 103 · see citing works
Self-citationSchmiedel, B. J., González-Colín, C., Fajardo, V., Rocha, J., Madrigal, A., Ramírez-Suástegui, C., Bhattacharyya, S., Simon, H. A., Greenbaum, J., Peters, B., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm2508 · Cited by 96 · see citing works
Self-citationMultiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Naulaerts, S., Datsi, A., Borràs, D., Antoranz, A., Messiaen, J., Vanmeerbeek, I., Sprooten, J., Laureano, R. S., Govaerts, J., Panovska, D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add1016 · Cited by 95 · see citing works
Stable gene expression for normalisation and single-sample scoring
Bhuva, D. D., Cursons, J., & Davis, M. J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa802 · Cited by 94 · see citing works
Zheng, W., Wang, X., Liu, J., Yu, X., Lu, L., Wang, H., Yu, J., Pei, X., Li, C., Wang, Z., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204289119 · Cited by 94 · see citing works
López‐Isac, E., Smith, S. L., Marion, M. C., Wood, A., Sudman, M., Yarwood, A., Shi, C., Gaddi, V. P., Martin, P., Prahalad, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218481 · Cited by 87 · see citing works
Dorajoo, R., Chang, X., Gurung, R. L., Li, Z., Wang, L., Wang, R., Beckman, K. B., Adams‐Haduch, J. M., Yiamunaa, M., Liu, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10443-2 · Cited by 84 · see citing works
Genome-wide association study of long COVID
Lammi, V., Nakanishi, T., Jones, S. E., Andrews, S. J., Karjalainen, J. M., Cortés, B., O’Brien, H., Ochoa-Guzmán, A., Fulton‐Howard, B., Broberg, M. E., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02100-w · Cited by 86 · see citing works
Ekiz, H. A., Conley, C. J., Stephens, W. Z., & O’Connell, R. M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3538-2 · Cited by 84 · see citing works
Wang, Y., Chen, S., Chen, J., Xie, X., Gao, S., Zhang, C., Zhou, S., Wang, J., Mai, R., Lin, Q., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215533 · Cited by 83 · see citing works
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
Li, Y., & Jiang, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128358 · Cited by 86 · see citing works
Global discovery of lupus genetic risk variant allelic enhancer activity
Lu, X., Chen, X., Forney, C. R., Donmez, O. A., Miller, D., Parameswaran, S., Hong, T., Huang, Y., Pujato, M. A., Cazares, T. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21854-5 · Cited by 74 · see citing works
Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms
Rubin, L. H., Neigh, G. N., Sundermann, E. E., Xu, Y., Scully, E. P., & Maki, P. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1089-x · Cited by 80 · see citing works
Yasumizu, Y., Ohkura, N., Murata, H., Kinoshita, M., Funaki, S., Nojima, S., Kido, K., Kohara, M., Motooka, D., Okuzaki, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31951-8 · Cited by 78 · see citing works
Eriksson, D., Røyrvik, E. C., Aranda‐Guillén, M., Berger, A. H., Landegren, N., Artaza, H., Hallgren, Å., Grytaas, M. A., Ström, S., Bratland, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21015-8 · Cited by 78 · see citing works
Lawlor, N. T., Nehar-Belaid, D., Grassmann, J. D. S., Stoeckius, M., Smibert, P., Stitzel, M. L., Pascual, V., Banchereau, J., Williams, A., & Ucar, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636720 · Cited by 80 · see citing works
Khunsriraksakul, C., Li, Q., Markus, H., Patrick, M. T., Sauteraud, R., McGuire, D., Wang, X., Wang, C., Wang, L., Chen, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36306-5 · Cited by 77 · see citing works
Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence
Huang, A. S., Ramos, V., Oliveira, T. Y., Gaebler, C., Janković, M., Nussenzweig, M. C., & Cohn, L. B. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211427 · Cited by 71 · see citing works
eQTL studies: from bulk tissues to single cells
Zhang, J., & Zhao, H. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.05.003 · Cited by 76 · see citing works
Lau, E. S., McNeill, J. N., Paniagua, S. M., Liu, E. E., Wang, J. K., Bassett, I. V., Selvaggi, C. A., Lubitz, S. A., Foulkes, A. S., & Ho, J. E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250774 · Cited by 65 · see citing works
The impact of cell type and context-dependent regulatory variants on human immune traits
Mu, Z., Wei, W., Fair, B. J., Miao, J., Zhu, P., & Li, Y. (2021) · Genome biology · doi:10.1186/s13059-021-02334-x · Cited by 67 · see citing works
Scully, E. P., Schumock, G., Fu, M., Massaccesi, G., Muschelli, J., Betz, J., Klein, E. Y., West, N. E., Robinson, M., Garibaldi, B. T., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab448 · Cited by 73 · see citing works
Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells
Lee, J. H., Toy, L., Kos, J. T., Safonova, Y., Schief, W. R., Havenar‐Daughton, C., Watson, C. T., & Crotty, S. (2021) · npj Vaccines · doi:10.1038/s41541-021-00376-7 · Cited by 72 · see citing works
Mouri, K., Guo, M. H., de Boer, C. G., Lissner, M. M., Harten, I. A., Newby, G. A., DeBerg, H. A., Platt, W. F., Gentili, M., Liu, D. R., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01056-5 · Cited by 71 · see citing works
Kachuri, L., Jeon, S., DeWan, A. T., Metayer, C., Ma, X., Witte, J. S., Chiang, C. W. K., Wiemels, J. L., & de Smith, A. J. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.08.004 · Cited by 70 · see citing works
Asian diversity in human immune cells
Kock, K. H., Tan, L. M., Han, K. Y., Ando, Y., Jevapatarakul, D., Chatterjee, A., Lin, Q. X. X., Buyamin, E. V., Sonthalia, R., Rajagopalan, D., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.017 · Cited by 84 · see citing works
Zhang, Z., Sun, Z., Fu, J., Lin, Q., Banu, K., Chauhan, K., Planoutene, M., Wei, C., Salem, F. E., Yi, Z., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146643 · Cited by 68 · see citing works
Wang, P., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814239 · Cited by 66 · see citing works
The X in seX-biased immunity and autoimmune rheumatic disease
Jiwrajka, N., & Anguera, M. C. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211487 · Cited by 67 · see citing works
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
Yasumizu, Y., Takeuchi, D., Morimoto, R., Takeshima, Y., Okuno, T., Kinoshita, M., Morita, T., Kato, Y., Wang, M., Motooka, D., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2023.100473 · Cited by 60 · see citing works
“Analysis of bulk RNA-seq of sorted peripheral CD4 + T cells provided by the DICE project 23 demonstrated that each fraction was well represented by the 12 NMF gene features (POH: 0.272; Evar all: 0.839, Figure S3D).”
BackgroundInfluentialCildir, G., Toubia, J., Yip, K. H., Zhou, M., Pant, H., Hissaria, P., Zhang, J., Hong, W., Robinson, N., Grimbaldeston, M. A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.021 · Cited by 65 · see citing works
scQTLbase: an integrated human single-cell eQTL database
Ding, R., Wang, Q., Gong, L., Zhang, T., Zou, X., Xiong, K., Liao, Q., Plass, M., & Li, L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad781 · Cited by 62 · see citing works
A Multi-Omics Perspective of Quantitative Trait Loci in Precision Medicine
Ye, Y., Zhang, Z., Liu, Y., Diao, L., & Han, L. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.01.009 · Cited by 64 · see citing works
Machine learning prediction of oncology drug targets based on protein and network properties
Dezső, Z., & Ceccarelli, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3442-9 · Cited by 64 · see citing works
- Authors
- Schmiedel, B. J., Singh, D., Madrigal, A., Valdovino-Gonzalez, A. G., White, B. M., Zapardiel-Gonzalo, J., Ha, B., Altay, G., Greenbaum, J. A., McVicker, G., Seumois, G., Rao, A., Kronenberg, M., Peters, B., & Vijayanand, P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Vijayanand, Pandurangan
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 175
- Issue
- 6
- Pages
- 1701-1715.e16
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6289654
- OpenAlex
- W2901765988
- Semantic Scholar
- 0b385de9f5adec440b108379bcbf8f8f00d13552
- Cited by
- 867
- References
- 68
- Citations by year
- 2026: 87 · 2025: 124 · 2024: 148 · 2023: 114 · 2022: 137 · 2021: 133 · 2020: 77 · 2019: 43 · 2018: 2
- FWCI
- 39.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- B.P. Koirala Institute of Health Sciences (S10RR027366, S10OD016262)
- National Institutes of Health (R24 AI108564)
- William K. Bowes, Jr. Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- genetic polymorphism, immune cell gene expression, cis-eQTL, expression quantitative trait loci, single-cell transcriptomics, sex differences in gene expression, cell type-specific gene regulation, immune cell types
- MeSH terms
- Adolescent, Adult, Female, Gene Expression Regulation, Genotype, Humans, Male, Middle Aged, Sex Characteristics, Polymorphism, Single Nucleotide, Gene Expression Profiling, Quantitative Trait Loci, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review